The ISCT Annual Meeting, hosted by the International Society for Cell & Gene Therapy, is one of the largest global conferences dedicated to advancing cell and gene therapy research and clinical translation. The event brings together thousands of scientists, clinicians, industry professionals, and regulators from more than 60 countries to share cutting-edge research, discuss emerging technologies, and address key challenges in developing and delivering advanced therapies.

Featuring hundreds of speakers, scientific presentations, and abstract sessions across a four-day program, the meeting focuses on accelerating innovation in areas such as gene editing, cell-based therapies, and biomanufacturing while fostering collaboration, networking, and partnerships that help translate scientific discoveries into real-world treatments for patients.

Date: May 6-9, 2026
Location: Convention Centre Dublin, Dublin, Ireland
Booth: #2204

JOIN US!

From autologous to allogeneic and iPSC-derived cell therapies, we provide flexible collaboration, tailored solutions, and proven operational excellence. Our white-glove case management delivers end-to-end professional supply chain coordination, helping teams bring transformative therapies to patients sooner. Come meet our cell therapy team at booth #2204 to discuss how we can accelerate your path forward.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS!

Date/Time: Thursday, May 7, 2026 at 13:30-13:45
Location: Theatre B, Liffey Floor (Level 1)
Title: GMP iPSC Lines and Manipulations Workflows: from Lessons Learned to Partnerships Easing Translation to Clinic and Patient Cures.
Speaker: Frederic Cedrone, Vice President Corporate Innovation, Catalent

NETWORKING EVENTS!

2026 ISCT Global Industry Networking Reception Sponsor

Date/Time: Thursday, May 7, 2026 at 19:00 – 22:30 GMT (local time)
Location: The Guinness Storehouse *transportation provided
Address: St. James’s Gate, Dublin 8, D08 VF8H, Ireland
This prestigious annual reception is the largest CGT translational networking event, bringing together academic visionaries, global regulatory experts, and industry decision-makers.

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™